<?xml version="1.0" encoding="UTF-8"?>
<p id="para120">Eligible participants were patients aged 18 years and older with previously untreated histologically confirmed peripheral T-cell lymphoma of the WHO 2008 subtypes:
 <xref rid="bib21" ref-type="bibr">
  <sup>21</sup>
 </xref> peripheral T-cell lymphoma not otherwise specified, angioimmunoblastic T-cell lymphoma, anaplastic lymphoma kinase (ALK) negative anaplastic large cell T-cell lymphoma, enteropathy-associated T-cell lymphoma, and hepatosplenic γδ T-cell lymphoma.
</p>
